Cite
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors.
MLA
He, Jun, et al. “Potential of Coronavirus 3C-like Protease Inhibitors for the Development of New Anti-SARS-CoV-2 Drugs: Insights from Structures of Protease and Inhibitors.” International Journal of Antimicrobial Agents, vol. 56, no. 2, Aug. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2020.106055.
APA
He, J., Hu, L., Huang, X., Wang, C., Zhang, Z., Wang, Y., Zhang, D., & Ye, W. (2020). Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors. International Journal of Antimicrobial Agents, 56(2), N.PAG. https://doi.org/10.1016/j.ijantimicag.2020.106055
Chicago
He, Jun, Lijun Hu, Xiaojun Huang, Chenran Wang, Zhimin Zhang, Ying Wang, Dongmei Zhang, and Wencai Ye. 2020. “Potential of Coronavirus 3C-like Protease Inhibitors for the Development of New Anti-SARS-CoV-2 Drugs: Insights from Structures of Protease and Inhibitors.” International Journal of Antimicrobial Agents 56 (2): N.PAG. doi:10.1016/j.ijantimicag.2020.106055.